Translational Development Acquisition Corp.
TDAC- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0001926599
No open-market purchases or sales by Translational Development Acquisition Corp. insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $154.1M in total; no superinvestor holds it.
Holders of 5% or more of TDAC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Translational Development Acquisition Corp., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Wolverine Asset Management LLC | 13G/A | 9.03%1.56M shares | +1.18 ppfrom 7.85% | May 1, 20253 filings | Oct 10, 2025 | SEC |
| AQR Capital Management LLC | 13G/A | 6.38%1.10M shares | −2.23 ppfrom 8.61% | Feb 14, 20252 filings | May 14, 2025 | SEC |
| Goldman Sachs Group Inc | 13G | 6.10%1.05M shares | New | May 13, 20261 filing | May 13, 2026 | SEC |
| Linden Capital L.P. | 13G | 5.50%950.0K shares | New | Jun 2, 20261 filing | Jun 2, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Translational Development Acquisition Corp., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 2, 20262:23 PM ET | Linden Capital L.P.and 3 others | 13G | 5.50%950.0K shares | New | May 27, 2026 | SEC |
| May 13, 202610:53 AM ET | Goldman Sachs Group Incand 1 other | 13G | 6.10%1.05M shares | New | Mar 31, 2026 | SEC |
| Oct 10, 20251:46 PM ET | Wolverine Asset Management LLCand 4 others | 13G/A | 9.03%1.56M shares | +1.18 ppfrom 7.85% | Sep 30, 2025 | SEC |
| Jul 31, 20254:56 PM ET | Bank of Montrealand 2 others | 13G/A | 4.64%800.0K shares | −1.15 ppfrom 5.79%Below 5% | Jun 30, 2025 | SEC |
| Jul 11, 202512:06 PM ET | Wolverine Asset Management LLCand 4 others | 13G/A | 7.85%1.35M shares | +1.61 ppfrom 6.24% | Jun 30, 2025 | SEC |
| May 14, 20254:15 PM ET | Healthcare of Ontario Pension Plan Trust Fund | 13G/A | 2.30%400.0K shares | −2.90 ppfrom 5.20%Below 5% | Mar 31, 2025 | SEC |
| May 14, 202512:33 PM ET | AQR Capital Management LLCand 2 others | 13G/A | 6.38%1.10M shares | −2.23 ppfrom 8.61% | Mar 31, 2025 | SEC |
| May 8, 20251:14 PM ET | Bank of Montrealand 2 others | 13G | 5.79%1.00M shares | New | Mar 31, 2025 | SEC |
| May 1, 20253:33 PM ET | Wolverine Asset Management LLCand 4 others | 13G | 6.24%1.08M shares | New | Mar 31, 2025 | SEC |
| Feb 14, 20254:01 PM ET | Healthcare of Ontario Pension Plan Trust Fund | 13G | 5.20%900.0K shares | New | Dec 31, 2024 | SEC |
| Feb 14, 202511:56 AM ET | AQR Capital Management LLCand 2 others | 13G | 8.61%1.49M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Translational Development Acquisition Corp. shares.
No Form 144 notices for Translational Development Acquisition Corp. are on file.